Skip to main content
TipRanks
Go Ultimate75% OFF

International Stem Cell (ISCO) Q4 2024 Earnings Report

45 Followers

ISCO Q4 2024 EPS Results

Actual EPS
-$0.03
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$0.03

ISCO Q4 2024 Revenue Results

Actual Revenue
$2.13M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+12.71%

Earnings Announcement Details

Quarter
Q4 2024
Date
03/31/2025
Time
Before Open
Conference Call
Monday, March 31, 2025

Q4 2024 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

ISCO Earnings History

ISCO earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 31, 20252024 (Q4)―-0.03-0.03-18.52% (-0.01)
May 16, 20242024 (Q1)―-0.030-575.00% (-0.02)
Apr 09, 20242023 (Q4)―-0.060-1325.00% (-0.05)
May 18, 20232023 (Q1)―-0.000-300.00% (-0.00)
Apr 11, 20232022 (Q4)―0.000400.00% (+0.00)
May 17, 20222022 (Q1)―-0.00-0.0898.75% (+0.08)
Mar 30, 20222021 (Q4)―-0.04-0.154.17% (+0.05)
Nov 15, 20192019 (Q3)―0.00-0.1100.00% (+0.10)
May 17, 20192019 (Q1)―--0.14―
May 17, 20192018 (Q4)―-0.12-0.1414.29% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed